World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

DXC Technology Schedules Fourth Quarter and Full Fiscal Year 2026 Earnings Release and Conference Call

Cision PR Newswire by Cision PR Newswire
April 14, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

ASHBURN, Va., April 14, 2026 /PRNewswire/ – DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced that it will release its fourth quarter and full fiscal year 2026 financial results on Thursday, May 7, 2026, after the market close.


DXC Technology Company Logo (CNW Group/DXC Technology Company)

Following the release, DXC Technology’s senior management will host a conference call and webcast at 5:00 p.m. ET. The dial-in number for domestic callers is 888-596-4144. Callers who reside outside of the United States should dial +1-646-968-2525. The passcode for all participants is 9664077#. A live webcast will be available on DXC Technology’s Investor Relations website.

A replay of the conference call will be available until 11:59 PM ET on May 14, 2026, at 800-770-2030. The replay passcode is 9664077#. A transcript of the conference call will be posted on DXC Technology’s Investor Relations website.

About DXC Technology

DXC Technology (NYSE: DXC) is a leading enterprise technology and innovation partner delivering software, services, and solutions to global enterprises and public sector organizations — helping them harness AI to drive outcomes at a time of exponential change with speed.  With deep expertise in Managed Infrastructure Services, Application Modernization, and Industry-Specific Software Solutions, DXC modernizes, secures, and operates some of the world’s most complex technology estates.  Learn more on DXC.com.

Forward-Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. For a written description of these factors, see the section titled “Risk Factors” in DXC’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and any updating information in subsequent SEC filings. No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dxc-technology-schedules-fourth-quarter-and-full-fiscal-year-2026-earnings-release-and-conference-call-302740900.html

SOURCE DXC Technology Company

Cision PR Newswire

Cision PR Newswire

Related Posts

Mexican company Farmacias Similares brings Dr. Simi to Tokyo in Japan debut

April 14, 2026

ImageTrend’s 2026 EMS Insights Report Reveals How Prehospital Care Is Evolving Nationwide

April 14, 2026

Wagner Reese Files Civil Suit Following 12-Count Conviction in Assault of Non-Verbal Child on Jennings County School Bus

April 14, 2026

Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

April 14, 2026

Americans’ views of China have grown somewhat more positive in recent years

April 14, 2026

At ASU+GSV, America Achieves Demonstrates Early Progress on Good Jobs Economy Core Commitments

April 14, 2026

Popular News

  • Wagner Reese Files Civil Suit Following 12-Count Conviction in Assault of Non-Verbal Child on Jennings County School Bus

    0 shares
    Share 0 Tweet 0
  • ImageTrend’s 2026 EMS Insights Report Reveals How Prehospital Care Is Evolving Nationwide

    0 shares
    Share 0 Tweet 0
  • Mexican company Farmacias Similares brings Dr. Simi to Tokyo in Japan debut

    0 shares
    Share 0 Tweet 0
  • Americans’ views of China have grown somewhat more positive in recent years

    0 shares
    Share 0 Tweet 0
  • Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler